Combined androgen blockade in the treatment of advanced prostate cancer--an overview. The Scandinavian Prostatic Cancer Group

P Iversen

Combined androgen blockade in the treatment of advanced prostate cancer--an overview. The Scandinavian Prostatic Cancer Group

P Iversen

5 Citations (Scopus)

Abstract

The value of combined androgen blockade in the treatment of patients with advanced prostate cancer is still controversial. In this review by the Scandinavian Prostatic Cancer Group, the literature addressing the concept and its clinical use is critically reviewed.

Original language	English
Journal	Scandinavian Journal of Urology and Nephrology
Volume	31
Issue number	3
Pages (from-to)	249-54
Number of pages	6
ISSN	0036-5599
Publication status	Published - 1997

Keywords

Androgen Antagonists
Chemotherapy, Adjuvant
Combined Modality Therapy
Humans
Male
Orchiectomy
Premedication
Prostate
Prostatectomy
Prostatic Neoplasms
Randomized Controlled Trials as Topic
Testis
Testosterone

Cite this

@article{a6b8d80fb7d54018975c929b2c4d6544,

title = "Combined androgen blockade in the treatment of advanced prostate cancer--an overview. The Scandinavian Prostatic Cancer Group",

abstract = "The value of combined androgen blockade in the treatment of patients with advanced prostate cancer is still controversial. In this review by the Scandinavian Prostatic Cancer Group, the literature addressing the concept and its clinical use is critically reviewed.",

keywords = "Androgen Antagonists, Chemotherapy, Adjuvant, Combined Modality Therapy, Humans, Male, Orchiectomy, Premedication, Prostate, Prostatectomy, Prostatic Neoplasms, Randomized Controlled Trials as Topic, Testis, Testosterone",

author = "P Iversen",

year = "1997",

language = "English",

volume = "31",

pages = "249--54",

journal = "Scandinavian Journal of Urology and Nephrology",

issn = "0036-5599",

publisher = "Taylor \& Francis",

number = "3",

}

TY - JOUR

T1 - Combined androgen blockade in the treatment of advanced prostate cancer--an overview. The Scandinavian Prostatic Cancer Group

AU - Iversen, P

PY - 1997

Y1 - 1997

N2 - The value of combined androgen blockade in the treatment of patients with advanced prostate cancer is still controversial. In this review by the Scandinavian Prostatic Cancer Group, the literature addressing the concept and its clinical use is critically reviewed.

AB - The value of combined androgen blockade in the treatment of patients with advanced prostate cancer is still controversial. In this review by the Scandinavian Prostatic Cancer Group, the literature addressing the concept and its clinical use is critically reviewed.

KW - Androgen Antagonists

KW - Chemotherapy, Adjuvant

KW - Combined Modality Therapy

KW - Humans

KW - Male

KW - Orchiectomy

KW - Premedication

KW - Prostate

KW - Prostatectomy

KW - Prostatic Neoplasms

KW - Randomized Controlled Trials as Topic

KW - Testis

KW - Testosterone

UR - https://www.scopus.com/pages/publications/0030841827

M3 - Journal article

C2 - 9249887

SN - 0036-5599

VL - 31

SP - 249

EP - 254

JO - Scandinavian Journal of Urology and Nephrology

JF - Scandinavian Journal of Urology and Nephrology

IS - 3

ER -

Combined androgen blockade in the treatment of advanced prostate cancer--an overview. The Scandinavian Prostatic Cancer Group

Abstract

Keywords

Other files and links

Fingerprint

Cite this